Medicine
Sevelamer 400 mg tablet
Sevelamer 400 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Sevelamer
- Brand
- Sold under the generic name
- Strength
- 400 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 360 tablets, 30 tablets and 2 more
- Manufacturers
- Glenmark PharmaceuticalsIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaBryant Ranch Prepack
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F) Do not use sevelamer hydrochloride tablets after the expiration date on the bottle. Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE02 Sevelamer
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 February 2019
- Identifiers
- RxCUI 857216, 857224DailyMed set ID 6926ebbe-2d74-4d5f-b642-c1bfe3a4e305, 2cd6512f-0edd-4a30-a4fa-aa996038633c, d8729e42-dbbd-4954-9ce0-298743a15a06 +1NDC 33342-241, 68462-446, 59651-087 +1Application ANDA206883, ANDA204724, ANDA212599
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 360 tablet, film coated in 1 bottle | 59651-087-36 | Aurobindo PharmaIndia | 11 July 2023 |
| 360 tablet, film coated in 1 bottle | 68462-446-26 | Glenmark PharmaceuticalsIndia | 8 February 2019 |
| 30 tablet, film coated in 1 bottle | 68462-446-30 | Glenmark PharmaceuticalsIndia | 8 February 2019 |
| 360 tablet, film coated in 1 bottle | 33342-241-65 | Macleods PharmaceuticalsIndia | 26 May 2023 |
| 360 tablet, film coated in 1 bottle | 72162-2500-2 | Bryant Ranch Prepack | 15 May 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sevelamer
Clinical summary
Sevelamer is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. MedsAcross supplies Sevelamer for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SevelamerFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Renvela prescribing information (Genzyme) · U.S. National Library of Medicine, DailyMed
- Renagel: European public assessment report (EPAR) · European Medicines Agency
- Renvela: European public assessment report (EPAR) · European Medicines Agency
Need Sevelamer 400 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.